Search

everythinglearnresearchcommunity

for

Search:↓

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

Ritlecitinib is safe and may effectively treat alopecia areata.

A(1-7) treatment reduces symptoms of lupus in mice.

Steroid 5α-reductase evolved from protists and diversified in eukaryotes, with specific roles in mammals and plants.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

The RHD4 gene is crucial for consistent root hair growth in Arabidopsis thaliana.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

The document's conclusion cannot be provided because the document is not available for parsing.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

5-Alpha-Reductase Inhibitors can cause negative side effects.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

The Fas/FasL pathway may play a role in alopecia areata.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Using 5 alpha reductase inhibitors may increase dementia risk in the first two years.

A new group called the Asian Association of Hair Restoration Surgeons (AAHRS) has been created.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

A Saudi individual initially identified as a girl had a genetic disorder affecting gender development.